Advertisement for orthosearch.org.uk
Results 1 - 3 of 3
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 92-B, Issue SUPP_III | Pages 434 - 434
1 Jul 2010
Bekic Z Mandaric D Vucinic Z Ilic V Tufegdzic I Sopta J
Full Access

Objective: The aim of our study was to evaluate results of chemotherapy regimens and analyse prognostics factors in children with relapse of osteosarcoma.

Patients and methods: From 2000–2007, we treated 57 patients with non metastatic osteosarcoma, median age 15,5 years (range 3–18). 29 pts relapsed. 26 pts with osteosarcoma relapse were treated, and 3 pts with OS relapse refused the treatment. In 24 pts pulmonary metastases were detected (7 solitary), while 2 pts had local relapse of disease. Disease free interval (DFI) was more than 1 year in 12 patients. Surgery was performed in 20 pts (17 thoracotomy, 3 amputation). Chemotherapy regimens administered were: HD IFO-VP16 (11 pts), HDMth/IFO-VP16 (6 pts), HDMth/Carbo-VP16 (9 pts).

Results : During 8–116 months follow up period (Me=32 mts), disease free suvival rate was 33.12%. There was no significant difference in survival in relation to the type of chemotherapy regimen applied.Prognostic factors that influenced survival were: presence of a solitary metastasis (p= 0.026), local relapse of disease (p= 0.002), completeness of resection (p=0.043) and DFIlonger than 1 year (p= 0.039).

Conclusion: The use of aggressive multimodal therapy (surgery/chemotherapy) and evaluation of prognostic factors are necessary for successful treatment in patients with osteosarcoma relapse. Chemotherapy regimen HD IFO-VP16 had better initial tumore response, but in longer follow up the survival rate was similar to other chemotherapy groups.


Orthopaedic Proceedings
Vol. 92-B, Issue SUPP_III | Pages 434 - 434
1 Jul 2010
Bokun J Bekic Z Grujicic D Minic L Sopta J
Full Access

Purpose: Treatment results in patients with Ewing tumors of the vertebrae were analyzed.

Patients and Methods: Between June 2000 and April 2007 7 patients with primary tumors of the thoracic or lumbar vertebrae were treated. No one patient had primary tumor of the cervical vertebra. The median ageat diagnosis was 13 years (range, 12 to 18 yrs.). Primary sites: thoracic5, lumbar 2. No one had metastases at diagnosis. Surgery was performed in 5 pts. Complete surgical excision in 2 and maximal tumor reduction in 3.Only biopsy was in 2pts. After surgery all pts. received chemotherapy: EICESS 92 (EVAIA chemotherapy regimen) in 4 pts. and Euro Ewing 99 in 3 pts. Radiotherapy was performed in 6 patients: after 2 cycles of chemotherapy in 2 pts., after 3 cycles in 4 pts. Median dose 5040cGy (range 5018–5400cGy) in conventional fractionation. Daily fractionation from 180–193cGy.

Results/Discussion: The mean follow-up was 41 months (range 4–104 months). Overall survival (OS) rate was 71,42 %. One patient progressed and died after complete treatment, another one died during chemotherapy before radiotherapy. In our series of Ewing’s Sarcoma of the vertebrae, good surgery initialy, early definitve radiotherapy and aggressive multimodal therapy (surgery/radiotherapy/chemotherapy) may be effective in disease control and survival.


Orthopaedic Proceedings
Vol. 92-B, Issue SUPP_III | Pages 477 - 477
1 Jul 2010
Sopta J Marinkovic J Mijucic V Vucunic Z Bokun J Ristic D Minic D
Full Access

Introduction: The prediction of clinical and biological behavior of bone tumors plays an important role in medical tasks such as diagnosis and treatment planning. Different prognostic factors for bone tumors outcome appear to be significant predictors for making definitive diagnosis. It is well-know that different clinical, radiological and histological characteristics are included in diagnostic process. The most important task for pathologist is to determinate biological behavior. Errors in diagnosis lead to wrong therapy and treatment.

It was reason to determinate scores for tumor diagnostics. Score is usually determinate using classic statistical methods such multivariate logistic regression (MVLR), but new computer tehniks, and models of artificial intelligence take a place in modern scoring systems. Recently, classifications tree analysis (CTA) and artificial neural network (ANN) models have become popular in decision-making and outcome prediction of clinical medicine, especially in oncology.

This study compared the levels of accuracy of MVLR, CTA and ANN model for the prediction of bone tumor’s biological behavior.

Material and method: Data from patient who had diagnosed bone tumors in Institute of pathology, School of Medicine in the period of 10 years (1995–2004) were used for analysis purposed in the study. In the analyzed date –base were 3689 biopsies with these criteria. About 24% (882 biopsies) were excluded because of missing data about radiological presentation. Consequently, data from 2807 biopsies were used for the analyses

Clinical, radiological, histological characteristics, summary 166 variables were analyzed and used to compare the levels of accuracy for the three methods of scoring.

All data were inserting in Spider 2.0 enterprise date-base who assisted MSSQL server 2000.

For MVLR and CTA we used SPSS 15.0 program with incorporate CTA. There are methods of multivariate analysis that allow for study of simultaneous influence of a series of independed variable on the one depended variable (biological behavior of bone tumors). The ANN model used in this study were feed-forward networks, witch were trained with a back propagation algorithm (NNSYSID-Neural Network Based System Identification Toolbox) situated in the Matlab area.

We compared three models across theirs overall percentages. The best model was one with highest overall percentage.

Results: From all analyzed cases 1590 (56, 6%) were males and 1217 (43, 4%) were females patients with Middle Ages 34, 1 (aged from 0–94 years). Malignant bone tumors (prime and metastatic lesions) were 1339 (47,7%) and benign 1468 (52,3%).

From all (166) characteristics 11 were selected on the bases of a definitive analysis and included into scoring system. From clinical characteristics just age of patient and clinical diagnosis “cyst” were included. Next radiological presentations: Pure osteolysis, osteolysis with cortical destruction, osteolysis with soft tissue mass, mixed lytic and sclerotic lesion was statistically significant for scoring model. Histological presents of fibroblasts, giant cells with hamosiderin pigment in stromal cells and atypical stromal cells, and hondroid stromal production were important for classification. Localization in finger’s bone was included in definitive score too.

Three performed scoring models showed wary high overall percentages in prediction biological behavior of bone tumors: MVLR 93, 77%, CTA 88, 2% and ANN 91, 5%. The most informative variable, rang 1 in both models of artificial intelligence was radiological criterion. For CTA it was radiological presents of lytic lesion with soft tissue mass and for ANN was combined lytic and sclerotic presentation.

Conclusions: All three scoring models are very useful in prediction bone’s tumor behavior, most of them each ones had priority versus others. The most successive (overall percentage 93, 77%) was MVLR. ANN had high sensitivity (overall percentage 93, 77%) and gave ranges of variables included in score. CTA algorithm had the least overall percentage but it is very simple and figurative for interpretation.